The Bill and Melinda Gates Foundation and a Canadian NGO on Friday announced $32 million to fund research for the discovery and development of affordable tools for rapidly diagnosing diseases in developing nations. The aim is to diagnose and treat illness on the spot in the rural regions of poor countries, and potentially save more lives now lost to delays. "Imagine a hand-held, battery-powered device that can take a drop of blood and, within minutes, tell a healthcare worker in a remote village whether a feverish child has malaria, dengue or a bacterial infection," said Peter Singer, head of Grand Challenges Canada which is partnering with the Microsoft founder Bill Gates's charitable organization on the project. "More rapid diagnosis of malaria alone could prevent 100,000 deaths a year." Gates's foundation is providing $21.1 million over three years to this research while Grand Challenges, backed by the Canadian government, is contributing $10.8 million, they said in a statement. The research will focus on five areas: drawing blood and prepping it for analysis, analyzing biological samples to identify diseases, developing technologies to obtain and transmit data and receive test results back, and ensuring these devices will work in the field where there is often no electricity or refrigeration.
GMT 16:03 2018 Wednesday ,28 November
Executive Office of Arab Ministers of Communications starts in CairoGMT 09:12 2018 Thursday ,15 November
Syria, Iran discuss enhancing scientific cooperationGMT 17:45 2018 Wednesday ,31 October
Next expedition may go to ISS on 3 DecemberGMT 13:56 2018 Saturday ,27 October
Head of Soviet space shuttle program dies aged 89GMT 15:58 2018 Monday ,15 October
Crew scheduled to go to ISS to remain unchangedGMT 10:57 2018 Saturday ,13 October
Expert says crewless ISS poses risk of station’s lossGMT 18:49 2018 Thursday ,11 October
Soyuz-FG suffers setback in 165th second of flightGMT 17:53 2018 Sunday ,07 October
Science, technologies to be bridge between Russian and JapanMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor